Cresset Discovery Services

Executive Summary

Cresset Discovery Services is a UK-based computational chemistry leader, offering AI-enriched simulation software and discovery services to accelerate drug design. With over two decades of experience, its platforms enable ligand- and structure-based design, scaffold hopping, and binding affinity prediction, helping pharmaceutical and biotech teams efficiently generate lead molecules. The company's integrated approach bridges computational predictions with experimental validation, making it a trusted partner in early-stage drug discovery. As AI-driven drug design gains momentum, Cresset is well-positioned to expand its client base and technology offerings.

Upcoming Catalysts (preview)

• Q3 2026New AI-Powered Platform Release70% success
• Q2 2026Strategic Partnership with Major Pharma50% success
• Q4 2026Publication of Benchmark Study Demonstrating Superior Performance60% success